Known for precision engineering, Danish design, and system architecture, X3D has established itself as a trusted force in nuclear medicine and molecular imaging. X3D’s flagship cardiac imaging system, ...

China approved on Thursday an innovative nuclear medicine imaging agent developed by a research team led by Professor Wang Fan at Peking University. The agent is the world's first radioactive drug ...

Dec. 4, 2002 (Chicago) - A radiopharmaceutical-imaging agent - ioflupane (I123-FP-CIT) - used with single photon emission computed tomography (SPECT) is "98% accurate" for early diagnosis of Parkinson ...

China has approved a domestically developed radioactive imaging drug to help detect whether lung cancer has spread to lymph ...

TORONTO, Canada--Researchers from Seoul National University confirmed that single photon emission computed tomography (SPECT) can be used to evaluate the effectiveness of stem cell therapy with ...

A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more personalized treatment.

U-SPECT 7 CT from MILabs (a Rigaku company) offers unmatched preclinical dynamic and whole body Single Photon Emission Computed Tomography (SPECT) performance, integrated with diagnostic micro-CT.

Bone SPECT/CT imaging – the integration of functional single photon emission computed tomography with anatomical computed tomography – represents a significant advancement in the evaluation of foot ...